Stock Earnings MBRX’s short interest surges to 1.93 million shares The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Analysts Viewpoint Monitoring Moleculin Biotech Inc (MBRX) after recent insider movements In a filing, Moleculin Biotech Inc revealed its Chief Financial Officer Foster Jonathan P. acquired Company’s shares for reported $100000.0